{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:21:21Z","timestamp":1767144081393,"version":"build-2238731810"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bcmd.2012.04.001","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T10:49:04Z","timestamp":1335955744000},"page":"41-47","source":"Crossref","is-referenced-by-count":9,"title":["Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs"],"prefix":"10.1016","volume":"49","author":[{"given":"Tereza","family":"Lopotov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Pol\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Klamov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Moravcov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2012.04.001_bb0005","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/sj.leu.2404878","article-title":"Effective treatment of leukemic cell lines with wt1 siRNA","volume":"21","author":"Glienke","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0010","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V87.7.2878.bloodjournal8772878","article-title":"Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis","volume":"87","author":"Yamagami","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2141.2001.02912.x","article-title":"Fluorescent 5\u2032-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias","volume":"114","author":"Kreuzer","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0020","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.leukres.2009.04.004","article-title":"High expression of WT1 gene in acute myeloid leukemias with more predominant WT1+17AA isoforms at relapse","volume":"34","author":"Gu","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2177\/jsci.31.375","article-title":"Cancer antigen WT1-targeting treatment for the malignancies","volume":"31","author":"Oka","year":"2008","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0035","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1074\/jbc.271.15.8646","article-title":"A non-AUG translational initiation event generates novel WT1 isoforms","volume":"271","author":"Bruening","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0040","doi-asserted-by":"crossref","first-page":"23456","DOI":"10.1074\/jbc.274.33.23456","article-title":"Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties","volume":"274","author":"Scharnhorst","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00066982-200005020-00005","article-title":"Detection of a novel truncated WT1 transcript in human neoplasia","volume":"5","author":"Dechsukhum","year":"2000","journal-title":"Mol. Diagn."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0050","doi-asserted-by":"crossref","first-page":"28122","DOI":"10.1074\/jbc.M512391200","article-title":"N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia","volume":"281","author":"Hossain","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1101\/gad.8.6.720","article-title":"RNA editing in the Wilms' tumor susceptibility gene, WT1","volume":"8","author":"Sharma","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1321494","article-title":"Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript","volume":"257","author":"Bickmore","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0065","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1073\/pnas.93.15.7562","article-title":"RNA binding by the Wilms tumor suppressor zinc finger proteins","volume":"93","author":"Caricasole","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0070","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1101\/gad.12.20.3217","article-title":"WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes","volume":"12","author":"Davies","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0075","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1101\/gad.1402306","article-title":"The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron","volume":"20","author":"Bor","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0080","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1535-7163.1467.3.11","article-title":"Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival","volume":"3","author":"Renshaw","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0085","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1038\/sj.onc.1209455","article-title":"Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway","volume":"25","author":"Ito","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00277-004-0941-0","article-title":"Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants","volume":"83","author":"Siehl","year":"2004","journal-title":"Ann. Hematol."},{"issue":"2009","key":"10.1016\/j.bcmd.2012.04.001_bb0095","first-page":"652","article-title":"Expression of four major WT1 splicing variants in AML and CML : development of quantitative real-time PCRs and preliminary results in patient samples","volume":"114","author":"Lopotov\u00e1","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.V116.21.2749.2749","article-title":"Expression analysis of WT1 splicing variants in CML and AML : \u22125\/+KTS as a novel candidate for early marker of relapse","volume":"116","author":"Lopotov\u00e1","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.leukres.2009.11.029","article-title":"Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes","volume":"34","author":"Tamura","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0115","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2012.04.001_bb0120","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.04.001_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.leukres.2006.07.021","article-title":"The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR","volume":"31","author":"Rulcova","year":"2007","journal-title":"Leuk. Res."}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2013.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:14:29Z","timestamp":1713914069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979612000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1079979612000861"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.04.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}